APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ceftriaxone

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Ceftriaxone Industry Growth and Trends Forecast to 2032

29 December 202595 pages

Choose your research edition.

Industry ResearchCeftriaxone Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Ceftriaxone Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Ceftriaxone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ceftriaxone Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Ceftriaxone Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Ceftriaxone market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Ceftriaxone is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Ceftriaxone is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ceftriaxone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Ceftriaxone include Qilu Pharmaceutical, Novartis, Baxter International, Orchid Pharma, Nectar Lifesciences, Lupin Pharmaceuticals, Hikma Pharmaceuticals, Aurobindo Pharma and ACS DOBFAR, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Ceftriaxone market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Ceftriaxone market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Ceftriaxone market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Ceftriaxone.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Ceftriaxone market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Ceftriaxone Market by Company

Qilu Pharmaceutical

Novartis

Baxter International

Orchid Pharma

Nectar Lifesciences

Lupin Pharmaceuticals

Hikma Pharmaceuticals

Aurobindo Pharma

ACS DOBFAR

Ceftriaxone Segment by Type

Intravenous Injection

Intramuscular Injection

Ceftriaxone Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Ceftriaxone Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ceftriaxone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ceftriaxone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ceftriaxone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Ceftriaxone manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Ceftriaxone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Intravenous Injection Table 2. Major Company of Intramuscular Injection Table 3. Global Ceftriaxone Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Ceftriaxone Sales by Type (2021-2026) & (K Units) Table 5. Global Ceftriaxone Sales Market Share in Volume by Type (2021-2026) Table 6. Global Ceftriaxone Sales by Type (2021-2026) & (US$ Million) Table 7. Global Ceftriaxone Sales Market Share in Value by Type (2021-2026) Table 8. Global Ceftriaxone Price by Type (2021-2026) & (US$/Unit) Table 9. Global Ceftriaxone Sales by Type (2027-2032) & (K Units) Table 10. Global Ceftriaxone Sales Market Share in Volume by Type (2027-2032) Table 11. Global Ceftriaxone Sales by Type (2027-2032) & (US$ Million) Table 12. Global Ceftriaxone Sales Market Share in Value by Type (2027-2032) Table 13. Global Ceftriaxone Price by Type (2027-2032) & (US$/Unit) Table 14. North America Ceftriaxone Sales by Type (2021-2026) & (K Units) Table 15. North America Ceftriaxone Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Ceftriaxone Sales by Type (2021-2026) & (K Units) Table 17. Europe Ceftriaxone Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Ceftriaxone Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Ceftriaxone Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Ceftriaxone Sales by Type (2021-2026) & (K Units) Table 21. Latin America Ceftriaxone Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Ceftriaxone Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Ceftriaxone Sales by Type (2021-2026) & (US$ Million) Table 24. Ceftriaxone Industry Trends Table 25. Ceftriaxone Industry Drivers Table 26. Ceftriaxone Industry Opportunities and Challenges Table 27. Ceftriaxone Industry Restraints Table 28. Global Ceftriaxone Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Ceftriaxone Revenue Market Share by Company (2021-2026) Table 30. Global Ceftriaxone Sales by Company (2021-2026) & (K Units) Table 31. Global Ceftriaxone Sales Share by Company (2021-2026) Table 32. Global Ceftriaxone Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Ceftriaxone Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Ceftriaxone Major Company Production Sites and Headquarters Table 35. Global Ceftriaxone Company, Product Type & Application Table 36. Global Ceftriaxone Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Ceftriaxone by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Ceftriaxone Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Ceftriaxone Sales by Region (2021-2026) & (K Units) Table 41. Global Ceftriaxone Sales Market Share in Volume by Region (2021-2026) Table 42. Global Ceftriaxone Sales by Region (2021-2026) & (US$ Million) Table 43. Global Ceftriaxone Sales Market Share in Value by Region (2021-2026) Table 44. Global Ceftriaxone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Ceftriaxone Sales by Region (2027-2032) & (K Units) Table 46. Global Ceftriaxone Sales Market Share in Volume by Region (2027-2032) Table 47. Global Ceftriaxone Sales by Region (2027-2032) & (US$ Million) Table 48. Global Ceftriaxone Sales Market Share in Value by Region (2027-2032) Table 49. Global Ceftriaxone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Ceftriaxone Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Ceftriaxone Sales by Application (2021-2026) & (K Units) Table 52. Global Ceftriaxone Sales Market Share in Volume by Application (2021-2026) Table 53. Global Ceftriaxone Sales by Application (2021-2026) & (US$ Million) Table 54. Global Ceftriaxone Sales Market Share in Value by Application (2021-2026) Table 55. Global Ceftriaxone Price by Application (2021-2026) & (US$/Unit) Table 56. Global Ceftriaxone Sales by Application (2027-2032) & (K Units) Table 57. Global Ceftriaxone Sales Market Share in Volume by Application (2027-2032) Table 58. Global Ceftriaxone Sales by Application (2027-2032) & (US$ Million) Table 59. Global Ceftriaxone Sales Market Share in Value by Application (2027-2032) Table 60. Global Ceftriaxone Price by Application (2027-2032) & (US$/Unit) Table 61. North America Ceftriaxone Sales by Application (2021-2026) & (K Units) Table 62. North America Ceftriaxone Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Ceftriaxone Sales by Application (2021-2026) & (K Units) Table 64. Europe Ceftriaxone Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Ceftriaxone Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Ceftriaxone Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Ceftriaxone Sales by Application (2021-2026) & (K Units) Table 68. Latin America Ceftriaxone Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Ceftriaxone Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Ceftriaxone Sales by Application (2021-2026) & (US$ Million) Table 71. Qilu Pharmaceutical Company Information Table 72. Qilu Pharmaceutical Business Overview Table 73. Qilu Pharmaceutical Ceftriaxone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Qilu Pharmaceutical Ceftriaxone Product Portfolio Table 75. Qilu Pharmaceutical Recent Development Table 76. Novartis Company Information Table 77. Novartis Business Overview Table 78. Novartis Ceftriaxone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Novartis Ceftriaxone Product Portfolio Table 80. Novartis Recent Development Table 81. Baxter International Company Information Table 82. Baxter International Business Overview Table 83. Baxter International Ceftriaxone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Baxter International Ceftriaxone Product Portfolio Table 85. Baxter International Recent Development Table 86. Orchid Pharma Company Information Table 87. Orchid Pharma Business Overview Table 88. Orchid Pharma Ceftriaxone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Orchid Pharma Ceftriaxone Product Portfolio Table 90. Orchid Pharma Recent Development Table 91. Nectar Lifesciences Company Information Table 92. Nectar Lifesciences Business Overview Table 93. Nectar Lifesciences Ceftriaxone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Nectar Lifesciences Ceftriaxone Product Portfolio Table 95. Nectar Lifesciences Recent Development Table 96. Lupin Pharmaceuticals Company Information Table 97. Lupin Pharmaceuticals Business Overview Table 98. Lupin Pharmaceuticals Ceftriaxone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Lupin Pharmaceuticals Ceftriaxone Product Portfolio Table 100. Lupin Pharmaceuticals Recent Development Table 101. Hikma Pharmaceuticals Company Information Table 102. Hikma Pharmaceuticals Business Overview Table 103. Hikma Pharmaceuticals Ceftriaxone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Hikma Pharmaceuticals Ceftriaxone Product Portfolio Table 105. Hikma Pharmaceuticals Recent Development Table 106. Aurobindo Pharma Company Information Table 107. Aurobindo Pharma Business Overview Table 108. Aurobindo Pharma Ceftriaxone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Aurobindo Pharma Ceftriaxone Product Portfolio Table 110. Aurobindo Pharma Recent Development Table 111. ACS DOBFAR Company Information Table 112. ACS DOBFAR Business Overview Table 113. ACS DOBFAR Ceftriaxone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. ACS DOBFAR Ceftriaxone Product Portfolio Table 115. ACS DOBFAR Recent Development Table 116. North America Ceftriaxone Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. North America Ceftriaxone Sales by Country (2021-2026) & (K Units) Table 118. North America Ceftriaxone Sales Market Share by Country (2021-2026) Table 119. North America Ceftriaxone Sales Forecast by Country (2027-2032) & (K Units) Table 120. North America Ceftriaxone Sales Market Share Forecast by Country (2027-2032) Table 121. North America Ceftriaxone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. North America Ceftriaxone Market Size by Country (2021-2026) & (US$ Million) Table 123. North America Ceftriaxone Market Share by Country (2021-2026) Table 124. North America Ceftriaxone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. North America Ceftriaxone Market Share Forecast by Country (2027-2032) Table 126. Europe Ceftriaxone Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. Europe Ceftriaxone Sales by Country (2021-2026) & (K Units) Table 128. Europe Ceftriaxone Sales Market Share by Country (2021-2026) Table 129. Europe Ceftriaxone Sales Forecast by Country (2027-2032) & (K Units) Table 130. Europe Ceftriaxone Sales Market Share Forecast by Country (2027-2032) Table 131. Europe Ceftriaxone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Europe Ceftriaxone Market Size by Country (2021-2026) & (US$ Million) Table 133. Europe Ceftriaxone Market Share by Country (2021-2026) Table 134. Europe Ceftriaxone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Europe Ceftriaxone Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Ceftriaxone Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Ceftriaxone Sales by Country (2021-2026) & (K Units) Table 138. Asia-Pacific Ceftriaxone Sales Market Share by Country (2021-2026) Table 139. Asia-Pacific Ceftriaxone Sales Forecast by Country (2027-2032) & (K Units) Table 140. Asia-Pacific Ceftriaxone Sales Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Ceftriaxone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Ceftriaxone Market Size by Country (2021-2026) & (US$ Million) Table 143. Asia-Pacific Ceftriaxone Market Share by Country (2021-2026) Table 144. Asia-Pacific Ceftriaxone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Asia-Pacific Ceftriaxone Market Share Forecast by Country (2027-2032) Table 146. Latin America Ceftriaxone Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Latin America Ceftriaxone Sales by Country (2021-2026) & (K Units) Table 148. Latin America Ceftriaxone Sales Market Share by Country (2021-2026) Table 149. Latin America Ceftriaxone Sales Forecast by Country (2027-2032) & (K Units) Table 150. Latin America Ceftriaxone Sales Market Share Forecast by Country (2027-2032) Table 151. Latin America Ceftriaxone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Latin America Ceftriaxone Market Size by Country (2021-2026) & (US$ Million) Table 153. Latin America Ceftriaxone Market Share by Country (2021-2026) Table 154. Latin America Ceftriaxone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Latin America Ceftriaxone Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Ceftriaxone Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Ceftriaxone Sales by Country (2021-2026) & (K Units) Table 158. Middle East and Africa Ceftriaxone Sales Market Share by Country (2021-2026) Table 159. Middle East and Africa Ceftriaxone Sales Forecast by Country (2027-2032) & (K Units) Table 160. Middle East and Africa Ceftriaxone Sales Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Ceftriaxone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Ceftriaxone Market Size by Country (2021-2026) & (US$ Million) Table 163. Middle East and Africa Ceftriaxone Market Share by Country (2021-2026) Table 164. Middle East and Africa Ceftriaxone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Middle East and Africa Ceftriaxone Market Share Forecast by Country (2027-2032) Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Ceftriaxone Distributors List Table 169. Ceftriaxone Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Ceftriaxone Image Figure 2. Global Ceftriaxone Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ceftriaxone Market Size (2021-2032) & (US$ Million) Figure 4. Global Ceftriaxone Sales (2021-2032) & (K Units) Figure 5. Intravenous Injection Image Figure 6. Global Intravenous Injection Sales YoY Growth (2021-2032) & (K Units) Figure 7. Intramuscular Injection Image Figure 8. Global Intramuscular Injection Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Ceftriaxone Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Ceftriaxone Market Share by Type 2025 VS 2032 Figure 11. North America Ceftriaxone Sales Market Share in Volume by Type in 2025 Figure 12. North America Ceftriaxone Sales Market Share in Value by Type in 2025 Figure 13. Europe Ceftriaxone Sales Market Share in Volume by Type in 2025 Figure 14. Europe Ceftriaxone Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Ceftriaxone Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Ceftriaxone Sales Market Share in Value by Type in 2025 Figure 17. Latin America Ceftriaxone Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Ceftriaxone Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Ceftriaxone Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Ceftriaxone Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Ceftriaxone Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Retail Pharmacies Image Figure 24. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 25. Online Pharmacies Image Figure 26. Global Online Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 27. Hospital Pharmacies Image Figure 28. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Ceftriaxone Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Ceftriaxone Market Share by Application 2025 VS 2032 Figure 31. North America Ceftriaxone Sales Market Share in Volume by Application in 2025 Figure 32. North America Ceftriaxone Sales Market Share in Value by Application in 2025 Figure 33. Europe Ceftriaxone Sales Market Share in Volume by Application in 2025 Figure 34. Europe Ceftriaxone Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Ceftriaxone Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Ceftriaxone Sales Market Share in Value by Application in 2025 Figure 37. Latin America Ceftriaxone Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Ceftriaxone Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Ceftriaxone Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Ceftriaxone Sales Market Share in Value by Application in 2025 Figure 41. North America Ceftriaxone Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Ceftriaxone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Ceftriaxone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Ceftriaxone Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Ceftriaxone Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Ceftriaxone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Ceftriaxone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Ceftriaxone Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Ceftriaxone Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Ceftriaxone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Ceftriaxone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Ceftriaxone Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Ceftriaxone Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Ceftriaxone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Ceftriaxone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Ceftriaxone Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Ceftriaxone Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Ceftriaxone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Ceftriaxone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Ceftriaxone Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Ceftriaxone Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Ceftriaxone Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Intravenous Injection
  • Intramuscular Injection
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Qilu Pharmaceutical
  • Novartis
  • Baxter International
  • Orchid Pharma
  • Nectar Lifesciences
  • Lupin Pharmaceuticals
  • Hikma Pharmaceuticals
  • Aurobindo Pharma
  • ACS DOBFAR

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ceftriaxone Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Ceftriaxone Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Ceftriaxone Market by Type
  6. 1.3.1 Intravenous Injection
  7. 1.3.2 Intramuscular Injection
  8. 1.4 Global Ceftriaxone Market Size by Type
  9. 1.4.1 Global Ceftriaxone Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Ceftriaxone Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Ceftriaxone Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Ceftriaxone Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Ceftriaxone Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Ceftriaxone Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Ceftriaxone Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Ceftriaxone Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Ceftriaxone Industry Trends
  2. 2.2 Ceftriaxone Industry Drivers
  3. 2.3 Ceftriaxone Industry Opportunities and Challenges
  4. 2.4 Ceftriaxone Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Ceftriaxone Revenue (2021-2026)
  2. 3.2 Global Top Players by Ceftriaxone Sales (2021-2026)
  3. 3.3 Global Top Players by Ceftriaxone Price (2021-2026)
  4. 3.4 Global Ceftriaxone Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Ceftriaxone Major Company Production Sites & Headquarters
  6. 3.6 Global Ceftriaxone Company, Product Type & Application
  7. 3.7 Global Ceftriaxone Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Ceftriaxone Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Ceftriaxone Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Ceftriaxone Tier 1, Tier 2, and Tier 3
4 Ceftriaxone Regional Status and Outlook
  1. 4.1 Global Ceftriaxone Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Ceftriaxone Historic Market Size by Region
  3. 4.2.1 Global Ceftriaxone Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Ceftriaxone Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Ceftriaxone Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Ceftriaxone Forecasted Market Size by Region
  7. 4.3.1 Global Ceftriaxone Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Ceftriaxone Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Ceftriaxone Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Ceftriaxone by Application
  1. 5.1 Ceftriaxone Market by Application
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Hospital Pharmacies
  5. 5.2 Global Ceftriaxone Market Size by Application
  6. 5.2.1 Global Ceftriaxone Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Ceftriaxone Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Ceftriaxone Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Ceftriaxone Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Ceftriaxone Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Ceftriaxone Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Ceftriaxone Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Ceftriaxone Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Qilu Pharmaceutical
  2. 6.1.1 Qilu Pharmaceutical Company Information
  3. 6.1.2 Qilu Pharmaceutical Business Overview
  4. 6.1.3 Qilu Pharmaceutical Ceftriaxone Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Qilu Pharmaceutical Ceftriaxone Product Portfolio
  6. 6.1.5 Qilu Pharmaceutical Recent Developments
  7. 6.2 Novartis
  8. 6.2.1 Novartis Company Information
  9. 6.2.2 Novartis Business Overview
  10. 6.2.3 Novartis Ceftriaxone Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novartis Ceftriaxone Product Portfolio
  12. 6.2.5 Novartis Recent Developments
  13. 6.3 Baxter International
  14. 6.3.1 Baxter International Company Information
  15. 6.3.2 Baxter International Business Overview
  16. 6.3.3 Baxter International Ceftriaxone Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Baxter International Ceftriaxone Product Portfolio
  18. 6.3.5 Baxter International Recent Developments
  19. 6.4 Orchid Pharma
  20. 6.4.1 Orchid Pharma Company Information
  21. 6.4.2 Orchid Pharma Business Overview
  22. 6.4.3 Orchid Pharma Ceftriaxone Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Orchid Pharma Ceftriaxone Product Portfolio
  24. 6.4.5 Orchid Pharma Recent Developments
  25. 6.5 Nectar Lifesciences
  26. 6.5.1 Nectar Lifesciences Company Information
  27. 6.5.2 Nectar Lifesciences Business Overview
  28. 6.5.3 Nectar Lifesciences Ceftriaxone Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Nectar Lifesciences Ceftriaxone Product Portfolio
  30. 6.5.5 Nectar Lifesciences Recent Developments
  31. 6.6 Lupin Pharmaceuticals
  32. 6.6.1 Lupin Pharmaceuticals Company Information
  33. 6.6.2 Lupin Pharmaceuticals Business Overview
  34. 6.6.3 Lupin Pharmaceuticals Ceftriaxone Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Lupin Pharmaceuticals Ceftriaxone Product Portfolio
  36. 6.6.5 Lupin Pharmaceuticals Recent Developments
  37. 6.7 Hikma Pharmaceuticals
  38. 6.7.1 Hikma Pharmaceuticals Company Information
  39. 6.7.2 Hikma Pharmaceuticals Business Overview
  40. 6.7.3 Hikma Pharmaceuticals Ceftriaxone Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Hikma Pharmaceuticals Ceftriaxone Product Portfolio
  42. 6.7.5 Hikma Pharmaceuticals Recent Developments
  43. 6.8 Aurobindo Pharma
  44. 6.8.1 Aurobindo Pharma Company Information
  45. 6.8.2 Aurobindo Pharma Business Overview
  46. 6.8.3 Aurobindo Pharma Ceftriaxone Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Aurobindo Pharma Ceftriaxone Product Portfolio
  48. 6.8.5 Aurobindo Pharma Recent Developments
  49. 6.9 ACS DOBFAR
  50. 6.9.1 ACS DOBFAR Company Information
  51. 6.9.2 ACS DOBFAR Business Overview
  52. 6.9.3 ACS DOBFAR Ceftriaxone Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 ACS DOBFAR Ceftriaxone Product Portfolio
  54. 6.9.5 ACS DOBFAR Recent Developments
7 North America by Country
  1. 7.1 North America Ceftriaxone Sales by Country
  2. 7.1.1 North America Ceftriaxone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Ceftriaxone Sales by Country (2021-2026)
  4. 7.1.3 North America Ceftriaxone Sales Forecast by Country (2027-2032)
  5. 7.2 North America Ceftriaxone Market Size by Country
  6. 7.2.1 North America Ceftriaxone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Ceftriaxone Market Size by Country (2021-2026)
  8. 7.2.3 North America Ceftriaxone Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Ceftriaxone Sales by Country
  2. 8.1.1 Europe Ceftriaxone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Ceftriaxone Sales by Country (2021-2026)
  4. 8.1.3 Europe Ceftriaxone Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Ceftriaxone Market Size by Country
  6. 8.2.1 Europe Ceftriaxone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Ceftriaxone Market Size by Country (2021-2026)
  8. 8.2.3 Europe Ceftriaxone Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Ceftriaxone Sales by Country
  2. 9.1.1 Asia-Pacific Ceftriaxone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Ceftriaxone Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Ceftriaxone Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Ceftriaxone Market Size by Country
  6. 9.2.1 Asia-Pacific Ceftriaxone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Ceftriaxone Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Ceftriaxone Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Ceftriaxone Sales by Country
  2. 10.1.1 South America Ceftriaxone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Ceftriaxone Sales by Country (2021-2026)
  4. 10.1.3 South America Ceftriaxone Sales Forecast by Country (2027-2032)
  5. 10.2 South America Ceftriaxone Market Size by Country
  6. 10.2.1 South America Ceftriaxone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Ceftriaxone Market Size by Country (2021-2026)
  8. 10.2.3 South America Ceftriaxone Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Ceftriaxone Sales by Country
  2. 11.1.1 Middle East and Africa Ceftriaxone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Ceftriaxone Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Ceftriaxone Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Ceftriaxone Market Size by Country
  6. 11.2.1 Middle East and Africa Ceftriaxone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Ceftriaxone Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Ceftriaxone Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Ceftriaxone Value Chain Analysis
  2. 12.1.1 Ceftriaxone Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Ceftriaxone Production Mode & Process
  7. 12.2 Ceftriaxone Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Ceftriaxone Distributors
  10. 12.2.3 Ceftriaxone Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst